Peregrine Ophthalmic
PrivateLast Round
Grant
Mar 9, 2015
Total Funding Raised
$3M
Company Overview
Peregrine Ophthalmic is a biotechnology company that develops and delivers new solutions for the management of intraorbital and periorbital eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peregrine Ophthalmic Comparables
Compare Peregrine Ophthalmic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PolyActiva | 85% | |
| Mati Therapeutics | 77% | |
| Ocular Therapeutix Inc | 76% | |
Peregrine Ophthalmic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 9, 2015 | ||||
| Seed | Aug 5, 2013 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 9, 2015
Secured $3M in grant funding.
- Aug 5, 2013
Completed a Seed funding round.
Peregrine Ophthalmic Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Peregrine Ophthalmic's valuation, stock price, and market status.